This is not the most recent version of the article. View current version (8 JUL 2009)

Intervention Review

You have free access to this content

Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings.

  1. Judd L Walson*,
  2. Grace John-Stewart

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 15 APR 2009

Assessed as up-to-date: 13 SEP 2007

DOI: 10.1002/14651858.CD006419.pub2

Database Title

Additional Information

How to Cite

Walson JL, John-Stewart G. Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings.. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006419. DOI: 10.1002/14651858.CD006419.pub2.

Author Information

  1. University of Washington, Allergy and Infectious Diseases, Seattle, WA, USA

*Judd L Walson, Allergy and Infectious Diseases, University of Washington, Box 359909, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA. walson@u.washington.edu.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 15 APR 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (08 Jul 2009)

View Full Article (HTML) Summary (61K)Standard (416K)Full (463K)
[Figure 1]
Figure 1. Flow chart of study selection process
[Analysis 1.1]
Analysis 1.1. Comparison 1 Viral Load, Outcome 1 Change in Log10 HIV-1 RNA after antihelminth treatment or no treament.
[Analysis 1.1.1]
Analysis 1.1.1. Comparison 1 Viral Load, Outcome 1 Change in Log10 HIV-1 RNA after antihelminth treatment or no treament, Subgroup 1 Randomized Controlled Trials.
[Analysis 1.1.2]
Analysis 1.1.2. Comparison 1 Viral Load, Outcome 1 Change in Log10 HIV-1 RNA after antihelminth treatment or no treament, Subgroup 2 Observational Studies (Helminth uninfected comparator group).
[Analysis 1.1.3]
Analysis 1.1.3. Comparison 1 Viral Load, Outcome 1 Change in Log10 HIV-1 RNA after antihelminth treatment or no treament, Subgroup 3 Observational Studies (Participants clearing helminth infection compared to participants without clearance).
[Analysis 2.1]
Analysis 2.1. Comparison 2 CD4 Count, Outcome 1 Decline in CD4 count after treatment of helminth co-infection.
[Analysis 2.1.1]
Analysis 2.1.1. Comparison 2 CD4 Count, Outcome 1 Decline in CD4 count after treatment of helminth co-infection, Subgroup 1 Randomized Controlled Trials.
[Analysis 2.1.2]
Analysis 2.1.2. Comparison 2 CD4 Count, Outcome 1 Decline in CD4 count after treatment of helminth co-infection, Subgroup 2 Observational Studies (Helminth uninfected comparator group).
[Analysis 2.1.3]
Analysis 2.1.3. Comparison 2 CD4 Count, Outcome 1 Decline in CD4 count after treatment of helminth co-infection, Subgroup 3 Observational Studies (Change in CD4 in the 6 months prior to treatment used as comparator group).
[Analysis 2.1.4]
Analysis 2.1.4. Comparison 2 CD4 Count, Outcome 1 Decline in CD4 count after treatment of helminth co-infection, Subgroup 4 Observational Studies (Participants clearing helminth infection compared to participants without clearance).
[Analysis 3.1]
Analysis 3.1. Comparison 3 Mortality differences, Outcome 1 Mortality differences between patients treated for helminth infection and helminth uninfected controls.
View Full Article (HTML) Summary (61K)Standard (416K)Full (463K)